These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34580007)

  • 1. Efficacy and validity of guideline-concordant treatment according to the JRS guidelines for the managements of pneumonia in adults updated in 2017 for nursing and healthcare-associated pneumonia. A propensity-matching score analysis.
    Asai N; Ohashi W; Watanabe H; Shiota A; Shibata Y; Kato H; Sakanashi D; Hagihara M; Koizumi Y; Yamagishi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2022 Jan; 28(1):24-28. PubMed ID: 34580007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score Matching.
    Baek MS; Baek AR; Hong SB; Bae S; Park HK; Kim C; Lee HK; Cho WH; Kim JH; Chang Y; Lee HB; Gil HI; Shin B; Yoo KH; Moon JY; Oh JY; Min KH; Jeon K;
    J Korean Med Sci; 2023 Oct; 38(41):e353. PubMed ID: 37873633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
    Mortensen EM; Restrepo M; Anzueto A; Pugh J
    Am J Med; 2004 Nov; 117(10):726-31. PubMed ID: 15541321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Older Adult Patients Surviving to Discharge.
    Corrales-Medina VF; van Walraven C
    Chest; 2023 Jun; 163(6):1380-1389. PubMed ID: 36621760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective open-label randomized comparative, non-inferiority study of two initial antibiotic strategies for patients with nursing- and healthcare-associated pneumonia: Guideline-concordant therapy versus empiric therapy.
    Matsuda S; Ogasawara T; Sugimoto S; Kato S; Umezawa H; Yano T; Kasamatsu N
    J Infect Chemother; 2016 Jun; 22(6):400-6. PubMed ID: 27062334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is antipseudomonal antibiotic treatment needed for all nursing and healthcare-associated pneumonia patients at risk for antimicrobial resistance?
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Yamazaki A; Washio Y
    J Glob Antimicrob Resist; 2020 Sep; 22():441-447. PubMed ID: 32339851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR; Restrepo MI; Mortensen EM; Burgess DS
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy and 48-hour mortality for patients with pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh JA
    Am J Med; 2006 Oct; 119(10):859-64. PubMed ID: 17000217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicenter survey for Nursing and Healthcare-associated Pneumonia in Japan.
    Imamura Y; Miyazaki T; Watanabe A; Tsukada H; Nagai H; Hasegawa Y; Tomono K; Ito I; Teramoto S; Ishida T; Kadota JI; Kohno S; Mukae H
    J Infect Chemother; 2022 Aug; 28(8):1125-1130. PubMed ID: 35414437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.
    Webb BJ; Dangerfield BS; Pasha JS; Agrwal N; Vikram HR
    Respir Med; 2012 Nov; 106(11):1606-12. PubMed ID: 22917808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis.
    Asai N; Suematsu H; Ohashi W; Shibata Y; Sakanashi D; Kato H; Shiota A; Watanabe H; Hagihara M; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2021 Oct; 27(10):1465-1470. PubMed ID: 34158237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.
    Hosogaya N; Takazono T; Ota K; Kiya R; Shirai Y; Kawasaki R; Yano H; Morimoto S; Nakao R; Kanamaru Y; Yoshino Y; Ishikawa Y; Fukushima C; Yamamoto H; Izumikawa K; Yanagihara K; Mukae H
    Medicine (Baltimore); 2023 Feb; 102(8):e33092. PubMed ID: 36827005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).
    Kaku N; Yanagihara K; Morinaga Y; Izumikawa K; Nagashima S; Kakeya H; Yamamoto Y; Fukuda M; Takatani H; Fukuda M; Hashiguchi K; Kohno S
    J Infect Chemother; 2013 Feb; 19(1):70-6. PubMed ID: 22850821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y
    J Infect Chemother; 2023 May; 29(5):437-442. PubMed ID: 36567049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An audit of empiric antibiotic choice in the inpatient management of community-acquired pneumonia.
    Delaney F; Jackson A
    Ir Med J; 2017 Apr; 110(4):545. PubMed ID: 28665084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of nursing and healthcare-associated pneumonia due to COVID-19.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Nomura S
    J Infect Chemother; 2022 Jul; 28(7):902-906. PubMed ID: 35317976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital.
    Cattani G; Madia A; Arnoldo L; Brunelli L; Celotto D; Grillone L; Valent F; Castriotta L; Pea F; Bassetti M; Brusaferro S
    Ann Ig; 2020; 32(4):344-356. PubMed ID: 32744293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.